Atlas FDA

Evoke SCS System

FDA premarket approval P190002/S022 · decided 2023-12-12

Approval details

PMA number
P190002
Supplement
S022
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Evoke SCS System
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Saluda Medical Pty, Ltd.
Date received
2023-11-20
Decision date
2023-12-12
Days to decision
22 days
Decision code
OK30
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Atarmon
Statement
approval for the current supplier of the rechargeable Lithium-Ion batteries to move to its new manufacturing facility

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.